 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval. |: P% J9 u9 @5 V$ a( F
+ M" s' F# Q1 a' x& N8 S
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
2 i* {$ |& V# h* ^) C8 S
$ h0 O5 U" E+ I; G& @, fBY THE EDMONTON JOURNAL FEBRUARY 16, 2007: R, q, f+ [" B6 ?
& g* g( [; M% k3 ]5 e: D1 @ 3 p) c% t0 t: t2 ^9 o
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.3 W; p% } Q( [4 V4 `* ^$ h; r) i8 G( [+ \
: C/ d2 \3 W% _6 Z6 u) Y2 f) o
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
& X& J1 S" m5 D; _7 B$ J& S0 F
4 t9 P* o# I3 @' yThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
: {2 _' v9 R8 E! o8 _ Q" U0 [$ c4 l' a' s1 c9 y
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.$ t- }5 |4 Z" w5 D& @
/ Q! g" ]1 A9 t* H( j0 [6 HIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million./ d1 P* J. w) {. ~/ F* e6 b
* h) m4 W6 ~( T
"As a scientist, it's one of the highlights of my CAREER," Shan said., V" V( X7 i: \3 O- r
0 b% `. H6 W D: M) p
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."9 D3 g+ s! N: i% z5 I
( _# I) o: j5 A& `6 z/ uIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.6 T! z; o" w, T4 K" C/ K
% J4 H1 ?1 i) h; Y2 q8 W
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
2 U; ?, S: q/ y8 _
0 F4 r- T! v. qThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
0 f" V7 b" f, C* y% k, h( M: J+ o' c& N4 g; a8 W
1 D4 ]& q( q- T" ^* }http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
8 A% o& }- {0 p- ^
发表于 2015-2-28 19:45
